id
stringlengths 8
10
| sequence
stringlengths 1
38M
| name
stringlengths 6
8
| description
stringlengths 3
342
| features
int64 1
461
| seq_length
int64 1
38M
|
|---|---|---|---|---|---|
DM462041.1
|
TGGAATACCGCCTCCTGCAG
|
DM462041
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 20
|
DM462042.1
|
CTTCTGCCCTTTGGAGAAGATGGC
|
DM462042
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462043.1
|
GGACTCACTGGCCCAGGCCTTCAATATCACCAGCCAGGACGAT
|
DM462043
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 43
|
DM462044.1
|
GTTGGATCTGGGCAACAATAAC
|
DM462044
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 22
|
DM462045.1
|
ATTGTTGTGCAGGCTGAGTTTAAG
|
DM462045
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462046.1
|
GGTGGCTATACATGGATAGCAATTACCTGGACACGCTGTCCCGGG
|
DM462046
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 45
|
DM462047.1
|
AGGGAGGATTATCCTTGACCTTTGAAGACC
|
DM462047
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 30
|
DM462048.1
|
GAAGCAAGTGCCCAGCTC
|
DM462048
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 18
|
DM462049.1
|
CGGGTCCCTGCTCTTTGG
|
DM462049
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 18
|
DM462050.1
|
CACCGTAGCTGGGAGCGCACTCAC
|
DM462050
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462051.1
|
AGTGTAAGTCAAGCTCCC
|
DM462051
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 18
|
DM462052.1
|
GCTTCCTGACACTAAGGCTGTCTGCTAGTCAGAATTGCCTCAAAAAGAG
|
DM462052
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 49
|
DM462053.1
|
AGCTGTGGTCATGGTGGTGTGGTG
|
DM462053
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462054.1
|
CTACCTTGGCCATAGGTGATCCGC
|
DM462054
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462055.1
|
CATCAGCAAACCGTCTGTGGTTCAGCTCAACTGGAGAGGGTT
|
DM462055
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 42
|
DM462056.1
|
AGCTTCTCAGCCCTCCTGGAGCAG
|
DM462056
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462057.1
|
CGGGTCAATAAACCTGGACGCTTGG
|
DM462057
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 25
|
DM462058.1
|
TATGTGGACCGGACCAAGCACTTCACTGAGGCCACCAAGATTG
|
DM462058
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 43
|
DM462059.1
|
CCCTGCAGTGCACCTACAGGGAAG
|
DM462059
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462060.1
|
CTGTCTTCCCCTGCTTGGCTGTGG
|
DM462060
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462061.1
|
GGTGCAGGAAGGGTGGGATCCTCTTCTCTCGCTGCTCTGGCCACATC
|
DM462061
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 47
|
DM462062.1
|
TCGTGCCCAGGGGCTGATGTGC
|
DM462062
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 22
|
DM462063.1
|
GTCTTTACCCAGCCCCGGGATGCG
|
DM462063
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462064.1
|
GGCCTAATCCAACGTTCTGTCTTCAATCTGCAAATCTATGGGGTCCTGGG
|
DM462064
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 50
|
DM462065.1
|
GTCCACAGACAGTCATCTCAGGAGCAG
|
DM462065
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 27
|
DM462066.1
|
ACAAGTGTCTTCCCAACCTG
|
DM462066
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 20
|
DM462067.1
|
ATCCTCCCAGAGCCATGGTACCTC
|
DM462067
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462068.1
|
CCAAGGATAGCTGTTGTTTCAGAGAAAGGATCGTGTGCTGCATCTCCTCCT
|
DM462068
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 51
|
DM462069.1
|
CCGAGGCCATCTAGAGGCCAGAGC
|
DM462069
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462070.1
|
ACAGGCAGAGCCAATGGCCAGAGC
|
DM462070
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462071.1
|
GAGAGGACTGCGGGAGTTTGGGACCTTTGTGCAGACGTGCTCATG
|
DM462071
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 45
|
DM462072.1
|
GCAGGCTTTGAGGATGAAGGCTGC
|
DM462072
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462073.1
|
CTCATTGGCTGCCTGGTCACAGGC
|
DM462073
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462074.1
|
CCAGTCGGACAGGTCTCTCCCCTC
|
DM462074
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462075.1
|
TCAGTGACCAAGGCTGAGCAGGCG
|
DM462075
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462076.1
|
CTACACTCGTTGCAAACTGGCAAAAATATTCTCGAGGGCTGGCCTGG
|
DM462076
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 47
|
DM462077.1
|
TCCTGTGAGCACGTGGTGTG
|
DM462077
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 20
|
DM462078.1
|
GGGTGGGATAGACCTGCG
|
DM462078
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 18
|
DM462079.1
|
AAGGCCAAGAAGGCTGCC
|
DM462079
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 18
|
DM462080.1
|
CCAGGCCTGCAGACCCAG
|
DM462080
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 18
|
DM462081.1
|
CTTCCTCAGTCCTTCCAGGATATC
|
DM462081
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462082.1
|
AAGCTGGATATCCTCCGTGTTGTC
|
DM462082
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462083.1
|
CCTGAAGAGGCATGACTGCTTTTCTCA
|
DM462083
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 27
|
DM462084.1
|
GGGGATAAACCTATTAATTATTGCTAC
|
DM462084
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 27
|
DM462085.1
|
AACGTCACCTACATCTCCTCGTGCCACATGCGCCAGGCCACCTG
|
DM462085
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 44
|
DM462086.1
|
TGTCCTTTGTCCCAGACTTCTGTCC
|
DM462086
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 25
|
DM462087.1
|
CTGGATGCTAATGTGTCCAGTAAATGATCCCCTTATCCCGTCGCGATGCT
|
DM462087
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 50
|
DM462088.1
|
GGCGAGCCCTAACTATCCAGGAG
|
DM462088
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 23
|
DM462089.1
|
GGAGATCGCTGCGCTGGCCAGGTCCTCCCTGCATGGTAT
|
DM462089
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 39
|
DM462090.1
|
CTGCTGCAAAGCGAGCCTCTTG
|
DM462090
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 22
|
DM462091.1
|
TGTGATTTTACAGAGTACTGCAATGGAACC
|
DM462091
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 30
|
DM462092.1
|
TTCTTTAAAACAGGCAAATGGAGCACC
|
DM462092
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 27
|
DM462093.1
|
TGACACTTATGCATTGAATGGCCGTTTGTGCAAGTTGGGA
|
DM462093
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 40
|
DM462094.1
|
CACCAACCAACTGCCAATCCTGGC
|
DM462094
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462095.1
|
ACCACATTCTGATGGGTGTCTCCTGG
|
DM462095
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 26
|
DM462096.1
|
GGGTCCCTACCTTTACCAGTGGAATGATGACAGGTGTAACATGAAGCAC
|
DM462096
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 49
|
DM462097.1
|
CCACTTGCCATGAACATGCCAC
|
DM462097
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 22
|
DM462098.1
|
CCTCTTGACAGACATAGCGAGCCAC
|
DM462098
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 25
|
DM462099.1
|
CACTCTTGTCTGTGGGAACCACACATCTTGCCACAACTGTGGC
|
DM462099
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 43
|
DM462100.1
|
GCTCTGTCTCTACCTGGAGCTACAATGTGTG
|
DM462100
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 31
|
DM462101.1
|
TTGGCATAGATGCCAACATCAGCTCTC
|
DM462101
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 27
|
DM462102.1
|
GAGCCCGATTCACTGCAAACTGTGAACATCTCTGTAATCTCCAAGCC
|
DM462102
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 47
|
DM462103.1
|
CCTGTCGTTCGCAGAGTCCGCTC
|
DM462103
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 23
|
DM462104.1
|
CACACAGAGGTTCCGGCACCTCTC
|
DM462104
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462105.1
|
TCCTGCAGGCGGCAGATCTGGGAGTAGGTGTGACCGTC
|
DM462105
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 38
|
DM462106.1
|
ACAACTGCATAGAAGCCCACAACG
|
DM462106
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462107.1
|
ACAACTGCATAGAAGCCCACAACGAATGGCG
|
DM462107
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 31
|
DM462108.1
|
TCTCCCCGTTGGCTTCAGAAATGG
|
DM462108
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462109.1
|
CGCCATTCGTTGTGGGCTTCTATGCAGTTGT
|
DM462109
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 31
|
DM462110.1
|
GGTTAGGTGGAATAAAGTCATTCACACCAAGACATGCCATTACGGCTTGG
|
DM462110
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 50
|
DM462111.1
|
GAGCTGGATCTGCAGAGGAACTAC
|
DM462111
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462112.1
|
AGGAACCACTCCAGGACGTTGTAG
|
DM462112
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 24
|
DM462113.1
|
CTTTCGACGGCCTGGCTGAGCTGAGGCACCTCAACCTGGCCTTCAA
|
DM462113
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 46
|
DM462114.1
|
CCTATAAGGGCTACAAAAACCGCGTGG
|
DM462114
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 27
|
DM462115.1
|
AGCACTGCACAGACAGAGTCTCCCCTT
|
DM462115
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 27
|
DM462116.1
|
CAACATCACCATGGTGGCCCTCAAGCTCCAGGACTCAGG
|
DM462116
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 39
|
DM462117.1
|
TTCCACTCAATGAGGTGAGCCACTC
|
DM462117
|
GENE DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
| 1
| 25
|
DM462118.1
|
AGTAGAAGGTGGCGCGAAGG
|
DM462118
|
METHODS AND COMPOSITIONS FOR TARGETING RELT
| 1
| 20
|
DM462119.1
|
CTGCCCACAGACAAGATGGTAATCTC
|
DM462119
|
METHODS AND COMPOSITIONS FOR TARGETING RELT
| 1
| 26
|
DM462120.1
|
GGTGCATCGATGCAGGGGGG
|
DM462120
|
METHODS AND COMPOSITIONS FOR TARGETING RELT
| 1
| 20
|
DM462121.1
|
ATGGGGCGCCCACTGCACCTCGTCCTGCTCAGTGCCTCCCTGGCTGGCCTCCTGCTGCTCGGGGAAAGTCTGTTCATCCGCAGGGAGCAGGCCAACAACATCCTGGCGAGGGTCACGAGGGCCAATTCCTTTCTTGAAGAGATGAAGAAAGGACACCTCGAAAGAGAGTGCATGGAAGAGACCTGCTCATACGAAGAGGCCCGCGAGGTCTTTGAGGACAGCGACAAGACGAATGAATTCTGGAATAAATACAAAGATGGCGACCAGTGTGAGACCAGTCCTTGCCAGAACCAGGGCAAATGTAAAGACGGCCTCGGGGAATACACCTGCACCTGTTTAGAAGGATTCGAAGGCAAAAACTGTGAATTATTCACACGGAAGCTCTGCAGCCTGGACAACGGGGACTGTGACCAGTTCTGCCACGAGGAACAGAACTCTGTGGTGTGCTCCTGCGCCCGCGGGTACACCCTGGCTGACAACGGCAAGGCCTGCATTCCCACAGGGCCCTACCCCTGTGGGAAACAGACCCTGGAACGCAGGAAGAGGTCAGTGGCCCAGGCCACCAGCAGCAGCGGGGAGGCCCCTGACAGCATCACATGGAAGCCATATGATGCAGCCGACCTGGACCCCACCGAGAACCCCTTCGACCTGCTTGACTTCAACCAGACGCAGCCTGAGAGGGGCGACAACAACCTCACCAGGATCGTGGGAGGCCAGGAATGCAAGGACGGGGAGTGTCCCTGGCAGGCCCTGCTCATCAATGAGGAAAACGAGGGTTTCTGTGGTGGAACCATTCTGAGCGAGTTCTACATCCTAACGGCAGCCCACTGTCTCTACCAAGCCAAGAGATTCAAGGTGAGGGTAGGGGACCGGAACACGGAGCAGGAGGAGGGCGGTGAGGCGGTGCACGAGGTGGAGGTGGTCATCAAGCACAACCGGTTCACAAAGGAGACCTATGACTTCGACATCGCCGTGCTCCGGCTCAAGACCCCCATCACCTTCCGCATGAACGTGGCGCCTGCCTGCCTCCCCGAGCGTGACTGGGCCGAGTCCACGCTGATGACGCAGAAGACGGGGATTGTGAGCGGCTTCGGGCGCACCCACGAGAAGGGCCGGCAGTCCACCAGGCTCAAGATGCTGGAGGTGCCCTACGTGGACCGCAACAGCTGCAAGCTGTCCAGCAGCTTCATCATCACCCAGAACATGTTCTGTGCCGGCTACGACACCAAGCAGGAGGATGCCTGCCAGGGGGACAGCGGGGGCCCGCACGTCACCCGCTTCAAGGACACCTACTTCGTGACAGGCATCGTCAGCTGGGGAGAGGGCTGTGCCCGTAAGGGGAAGTACGGGATCTACACCAAGGTCACCGCCTTCCTCAAGTGGATCGACAGGTCCATGAAAACCAGGGGCTTGCCCAAGGCCAAGAGCCATGCCCCGGAGGTCATAACGTCCTCTCCATTAAAGTGA
|
DM462121
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 1,467
|
DM462122.1
|
CAGGGACACAGTACTCGGCC
|
DM462122
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 20
|
DM462123.1
|
GAGTGGGATCTCACTTTAATGG
|
DM462123
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 22
|
DM462124.1
|
GCGGCTAGCATGGGGCGCCCACTGCACC
|
DM462124
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 28
|
DM462125.1
|
GCGGCGGCCGCTCACTTTAATGGAGAGGACGTTATG
|
DM462125
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 36
|
DM462126.1
|
CCTGGCGAGGGTCAGGAGGGCCAATTC
|
DM462126
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 27
|
DM462127.1
|
GAATTGGCCCTCCTGACCCTCGCCAGG
|
DM462127
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 27
|
DM462128.1
|
CAGACGCAGCCTACCCAATCATTTAATGACTTCACTCGGATCGTGGGAGG
|
DM462128
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 50
|
DM462129.1
|
CCTCCCACGATCCGAGTGAAGTCATTAAATGATTGGGTAGGCTGCGTCTG
|
DM462129
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 50
|
DM462130.1
|
GGCGACAACAACGACGACAGGATCGTGG
|
DM462130
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 28
|
DM462131.1
|
CCACGATCCTGTCGTCGTTGTTGTCGCC
|
DM462131
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 28
|
DM462132.1
|
GCAGGAAGAGGACCCAATCATTTAATGACTTC
|
DM462132
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 32
|
DM462133.1
|
GAAGTCATTAAATGATTGGGTCCTCTTCCTGC
|
DM462133
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 32
|
DM462134.1
|
CGACTTCACCCGCGTCGTGGGAGGC
|
DM462134
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 25
|
DM462135.1
|
GCCTCCCACGACGCGGGTGAAGTCG
|
DM462135
|
Coagulation factor X polypeptides with modified activation properties
| 1
| 25
|
DM462136.1
|
ATGGCCTGGGCTCTGCTGCTCCTCACCCTCCTCACTCAGGGCACAGGATCCTGGGCTGATATCGAACTGACCCAGCCGCCTTCAGTGAGCGTTGCACCAGGTCAGACCGCGCGTATCTCGTGTGGCGGCGATTCTCTTGGTGGTAAGTATGTTTATTGGTACCAGCAGAAACCCGGGCAGGCGCCAGTTCTTGTGATTTATGGTGATTCTAAGCGTCCCTCAGGCATCCCGGAACGCTTTAGCGGATCCAACAGCGGCAACACCGCGACCCTGACCATTAGCGGCACTCAGGCGGAAGACGAAGCGGATTATTATTGCCAGTCTTATGATCTTAAGTCTCTTAATGTTGTGTTTGGCGGCGGCACGAAGTTAACCGTCCTAGGTCAGCCCAAGGCTGCCCCCTCGGTCACTCTGTTCCCGCCCTCCTCTGAGGAGCTTCAAGCCAACAAGGCCACACTGGTGTGTCTCATAAGTGACTTCTACCCGGGAGCCGTGACAGTGGCCTGGAAGGCAGATAGCAGCCCCGTCAAGGCGGGAGTGGAGACCACCACACCCTCCAAACAAAGCAACAACAAGTACGCGGCCAGCAGCTATCTGAGCCTGACGCCTGAGCAGTGGAAGTCCCACAGAAGCTACAGCTGCCAGGTCACGCATGAAGGGAGCACCGTGGAGAAGACAGTGGCCCCTACAGAATGTTCA
|
DM462136
|
THYMIC STROMAL LYMPHOPOIETIN (TSLP) ANTIBODIES AND USES THEREOF
| 1
| 699
|
DM462137.1
|
ATGAGTGTGCTCACTCAGGTCCTGGCGTTGCTGCTGCTGTGGCTTACAGGTACGCGTTGCGACATCGAGCTGACCCAGCCCCCCAGCGTGTCTGTGGCCCCTGGCCAGACCGCCCGGATCAGCTGTGGCGGCGACAGCCTGGGCGGCAAGTACGTGTACTGGTATCAGCAGAAGCCCGGCCAGGCCCCCGTGCTGGTGATCTACGGCGACAGCAAGCGGCCCAGCGGCATCCCCGAGCGGTTCAGCGGCAGCAACAGCGGCAACACCGCCACCCTGACCATCAGCGGCACCCAGGCCGAGGACGAGGCCGACTACTACTGCCAGAGCTACGACCTGAAGAGCCTGAACGTGGTGTTTGGCGGCGGAACAAAGCTTACCGTCCTAGGTCAGCCCAAGGCTGCCCCCTCGGTCACTCTGTTCCCGCCCTCCTCTGAGGAGCTTCAAGCCAACAAGGCCACACTGGTGTGTCTCATAAGTGACTTCTACCCGGGAGCCGTGACAGTGGCCTGGAAGGCAGATAGCAGCCCCGTCAAGGCGGGAGTGGAGACAACCACACCCTCCAAACAAAGCAACAACAAGTACGCGGCCAGCAGCTATCTGAGCCTGACGCCTGAGCAGTGGAAGTCCCACAGAAGCTACAGCTGCCAGGTCACGCATGAAGGGAGCACCGTGGAAAAGACAGTGGCCCCTACAGAATGTTCATAG
|
DM462137
|
THYMIC STROMAL LYMPHOPOIETIN (TSLP) ANTIBODIES AND USES THEREOF
| 1
| 705
|
DM462138.1
|
ATGAAACACCTGTGGTTCTTCCTCCTGCTGGTGGCAGCTCCCAGATGGGTCCTGTCCCAGGTGCAATTGGTGGAAAGCGGCGGCGGCCTGGTGCAACCGGGCGGCAGCCTGCGTCTGAGCTGCGCGGCCTCCGGATTTACCTTTTCTTCTTATTATATGTCTTGGGTGCGCCAAGCCCCTGGGAAGGGTCTCGAGTGGGTGAGCGGTATTTTTTTTGATGGTGAGACTTATTATGCTGATTCTGTTAAGGGTCGTTTTACCATTTCACGTGATAATTCGAAAAACACCCTGTATCTGCAAATGAACAGCCTGCGTGCGGAAGATACGGCCGTGTATTATTGCGCGCGTCAGCAGTATTTTGATCATATTGATATTTGGGGCCAAGGCACCCTGGTGACGGTTAGCTCAGCCTCCACCAAGGGTCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGGCACAGCGGCCCTGGGCTGCCTGGTCAAGGACTACTTCCCCGAACCGGTGACGGTGTCGTGGAACTCAGGCGCCCTGACCAGCGGCGTGCACACCTTCCCGGCTGTCCTACAGTCCTCAGGACTCTACTCCCTCAGCAGCGTGGTGACCGTGCCCTCCAGCAGCTTGGGCACCCAGACCTACATCTGCAACGTGAATCACAAGCCCAGCAACACCAAGGTGGACAAGAGAGTTGAGCCCAAATCTTGTGACAAAACTCACACATGCCCACCGTGCCCAGCACCTGAACTCCTGGGGGGACCGTCAGTCTTCCTCTTCCCCCCAAAACCCAAGGACACCCTCATGATCTCCCGGACCCCTGAGGTCACATGCGTGGTGGTGGACGTGAGCCACGAAGACCCTGAGGTCAAGTTCAACTGGTACGTGGACGGCGTGGAGGTGCATAATGCCAAGACAAAGCCGCGGGAGGAGCAGTACAACAGCACGTACCGGGTGGTCAGCGTCCTCACCGTCCTGCACCAGGACTGGCTGAATGGCAAGGAGTACAAGTGCAAGGTCTCCAACAAAGCCCTCCCAGCCCCCATCGAGAAAACCATCTCCAAAGCCAAAGGGCAGCCCCGAGAACCACAGGTGTACACCCTGCCCCCATCCCGGGAGGAGATGACCAAGAACCAGGTCAGCCTGACCTGCCTGGTCAAAGGCTTCTATCCCAGCGACATCGCCGTGGAGTGGGAGAGCAATGGGCAGCCGGAGAACAACTACAAGACCACGCCTCCCGTGCTGGACTCCGACGGCTCCTTCTTCCTCTACAGCAAGCTCACCGTGGACAAGAGCAGGTGGCAGCAGGGGAACGTCTTCTCATGCTCCGTGATGCATGAGGCTCTGCACAACCACTACACGCAGAAGAGCCTCTCCCTGTCTCCGGGTAAATGA
|
DM462138
|
THYMIC STROMAL LYMPHOPOIETIN (TSLP) ANTIBODIES AND USES THEREOF
| 1
| 1,401
|
DM462139.1
|
ATGGCTTGGGTGTGGACCTTGCCATTCCTGATGGCAGCTGCCCAAAGTGTCCAGGCCCAGGTGCAGCTGGTGGAATCTGGCGGCGGACTGGTGCAGCCTGGCGGCAGCCTGAGACTGAGCTGCGCCGCCAGCGGCTTCACCTTCAGCAGCTACTACATGAGCTGGGTGCGGCAGGCCCCTGGCAAGGGCCTGGAATGGGTGTCCGGCATCTTCTTCGACGGCGAGACCTACTACGCCGACAGCGTGAAGGGCCGGTTCACCATCAGCCGGGACAACAGCAAGAACACCCTGTACCTGCAGATGAACAGCCTGCGGGCCGAGGACACCGCCGTGTACTACTGCGCCAGGCAGCAGTACTTCGACCACATCGACATCTGGGGCCAGGGCACCCTGGTCACCGTCTCCTCAGCCTCCACCAAGGGCCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGGCACAGCGGCCCTGGGCTGCCTGGTCAAGGACTACTTCCCCGAACCGGTGACGGTGTCGTGGAACTCAGGCGCCCTGACCAGCGGCGTGCACACCTTCCCGGCTGTCCTACAGTCCTCAGGACTCTACTCCCTCAGCAGCGTCGTGACCGTGCCCTCCAGCAGCTTGGGCACCCAGACCTACATCTGCAACGTGAATCACAAGCCCAGCAACACCAAGGTGGACAAGAGAGTTGAGCCCAAATCTTGTGACAAAACTCACACATGCCCACCGTGCCCAGCACCTGAACTCCTGGGGGGACCGTCAGTCTTCCTCTTCCCCCCAAAACCCAAGGACACCCTCATGATCTCCCGGACCCCTGAGGTCACATGCGTGGTGGTGGACGTGAGCCACGAAGACCCTGAGGTCAAGTTCAACTGGTACGTGGACGGCGTGGAGGTGCATAATGCCAAGACAAAGCCGCGGGAGGAGCAGTACAACAGCACGTACCGTGTGGTCAGCGTCCTCACCGTCCTGCACCAGGACTGGCTGAATGGCAAGGAGTACAAGTGCAAGGTCTCCAACAAAGCCCTCCCAGCCCCCATCGAGAAAACCATCTCCAAAGCCAAAGGGCAGCCCCGAGAACCACAGGTGTACACCCTGCCCCCATCCCGGGAGGAGATGACCAAGAACCAGGTCAGCCTGACCTGCCTGGTCAAAGGCTTCTATCCCAGCGACATCGCCGTGGAGTGGGAGAGCAATGGGCAGCCGGAGAACAACTACAAGACCACGCCTCCCGTGCTGGACTCCGACGGCTCCTTCTTCCTCTATAGCAAGCTCACCGTGGACAAGAGCAGGTGGCAGCAGGGGAACGTCTTCTCATGCTCCGTGATGCATGAGGCTCTGCACAACCACTACACGCAGAAGAGCCTCTCCCTGTCCCCGGGTAAATGA
|
DM462139
|
THYMIC STROMAL LYMPHOPOIETIN (TSLP) ANTIBODIES AND USES THEREOF
| 1
| 1,401
|
DM462140.1
|
ATGAAACACCTGTGGTTCTTCCTCCTGCTGGTGGCAGCTCCCAGATGGGTCCTGTCCCAGGTGCAATTGGTGGAAAGCGGCGGCGGCCTGGTGCAACCGGGCGGCAGCCTGCGTCTGAGCTGCGCGGCCTCCGGATTTACCTTTTCTTCTTATTATATGTCTTGGGTGCGCCAAGCCCCTGGGAAGGGTCTCGAGTGGGTGAGCGGTATTTTTTTTGATGGTACTACTTATTATGCTGATTCTGTTAAGGGTCGTTTTACCATTTCACGTGATAATTCGAAAAACACCCTGTATCTGCAAATGAACAGCCTGCGTGCGGAAGATACGGCCGTGTATTATTGCGCGCGTCAGCAGTATTTTGATCATATTGATATTTGGGGCCAAGGCACCCTGGTGACGGTTAGCTCAGCCTCCACCAAGGGTCCATCGGTCTTCCCCCTGGCACCCTCCTCCAAGAGCACCTCTGGGGGCACAGCGGCCCTGGGCTGCCTGGTCAAGGACTACTTCCCCGAACCGGTGACGGTGTCGTGGAACTCAGGCGCCCTGACCAGCGGCGTGCACACCTTCCCGGCTGTCCTACAGTCCTCAGGACTCTACTCCCTCAGCAGCGTGGTGACCGTGCCCTCCAGCAGCTTGGGCACCCAGACCTACATCTGCAACGTGAATCACAAGCCCAGCAACACCAAGGTGGACAAGAGAGTTGAGCCCAAATCTTGTGACAAAACTCACACATGCCCACCGTGCCCAGCACCTGAACTCCTGGGGGGACCGTCAGTCTTCCTCTTCCCCCCAAAACCCAAGGACACCCTCATGATCTCCCGGACCCCTGAGGTCACATGCGTGGTGGTGGACGTGAGCCACGAAGACCCTGAGGTCAAGTTCAACTGGTACGTGGACGGCGTGGAGGTGCATAATGCCAAGACAAAGCCGCGGGAGGAGCAGTACAACAGCACGTACCGGGTGGTCAGCGTCCTCACCGTCCTGCACCAGGACTGGCTGAATGGCAAGGAGTACAAGTGCAAGGTCTCCAACAAAGCCCTCCCAGCCCCCATCGAGAAAACCATCTCCAAAGCCAAAGGGCAGCCCCGAGAACCACAGGTGTACACCCTGCCCCCATCCCGGGAGGAGATGACCAAGAACCAGGTCAGCCTGACCTGCCTGGTCAAAGGCTTCTATCCCAGCGACATCGCCGTGGAGTGGGAGAGCAATGGGCAGCCGGAGAACAACTACAAGACCACGCCTCCCGTGCTGGACTCCGACGGCTCCTTCTTCCTCTACAGCAAGCTCACCGTGGACAAGAGCAGGTGGCAGCAGGGGAACGTCTTCTCATGCTCCGTGATGCATGAGGCTCTGCACAACCACTACACGCAGAAGAGCCTCTCCCTGTCTCCGGGTAAATGA
|
DM462140
|
THYMIC STROMAL LYMPHOPOIETIN (TSLP) ANTIBODIES AND USES THEREOF
| 1
| 1,401
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.